CXCL8 and Miyoshi myopathy: We also observed that IL-8, an activator of osteoclast differentiation and bone resorption in MM, was expressed in both untreated controls and the IL-6-treated group, but IL-6 only increased in the IL-6-treated lysate group (Figure 1A, right).